BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31977897)

  • 1. A novel de novo MYH9 mutation in MYH9-related disease: A case report and review of literature.
    Ai Q; Zhao L; Yin J; Jiang L; Jin Q; Hu X; Chen S
    Medicine (Baltimore); 2020 Jan; 99(4):e18887. PubMed ID: 31977897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of
    Rabbolini DJ; Chun Y; Latimer M; Kunishima S; Fixter K; Valecha B; Tan P; Chew LP; Kile BT; Burt R; Radhakrishnan K; Bird R; Ockelford P; Gabrielli S; Chen Q; Stevenson WS; Ward CM; Morel-Kopp MC
    Platelets; 2018 Dec; 29(8):793-800. PubMed ID: 29090586
    [No Abstract]   [Full Text] [Related]  

  • 3. R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17.
    Verver E; Pecci A; De Rocco D; Ryhänen S; Barozzi S; Kunst H; Topsakal V; Savoia A
    Clin Genet; 2015 Jul; 88(1):85-9. PubMed ID: 24890873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.
    Verver EJ; Topsakal V; Kunst HP; Huygen PL; Heller PG; Pujol-Moix N; Savoia A; Benazzo M; Fierro T; Grolman W; Gresele P; Pecci A
    Ear Hear; 2016; 37(1):112-20. PubMed ID: 26226608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset and high-frequency dominant hearing loss in a family with MYH9 disorder.
    Wasano K; Matsunaga T; Ogawa K; Kunishima S
    Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3547-3552. PubMed ID: 26942920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure.
    Arif AR; Zhao M; Chen W; Xue M; Luo S; Wang Y
    Platelets; 2022 Nov; 33(8):1307-1311. PubMed ID: 35791514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial cases with MYH9 disorders caused by MYH9 S96L mutation.
    Murayama S; Akiyama M; Namba H; Wada Y; Ida H; Kunishima S
    Pediatr Int; 2013 Feb; 55(1):102-4. PubMed ID: 23409987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, pathological, and genetic analysis of ten patients with MYH9-related disease.
    Sun XH; Wang ZY; Yang HY; Cao LJ; Su J; Yu ZQ; Bai X; Ruan CG
    Acta Haematol; 2013; 129(2):106-13. PubMed ID: 23207509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heavy chain myosin 9-related disease (MYH9 -RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder.
    Savoia A; De Rocco D; Panza E; Bozzi V; Scandellari R; Loffredo G; Mumford A; Heller PG; Noris P; De Groot MR; Giani M; Freddi P; Scognamiglio F; Riondino S; Pujol-Moix N; Fabris F; Seri M; Balduini CL; Pecci A
    Thromb Haemost; 2010 Apr; 103(4):826-32. PubMed ID: 20174760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of mouse model of MYH9 disorders: heterozygous R702C mutation provokes macrothrombocytopenia with leukocyte inclusion bodies, renal glomerulosclerosis and hearing disability.
    Suzuki N; Kunishima S; Ikejiri M; Maruyama S; Sone M; Takagi A; Ikawa M; Okabe M; Kojima T; Saito H; Naoe T; Matsushita T
    PLoS One; 2013; 8(8):e71187. PubMed ID: 23976996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary thrombocytopenia with familial novel mutation in MYH9 gene: A familial case report.
    Ciftciler R; Balasar Ö; Keyik H; Ciftciler AE
    Transfus Apher Sci; 2023 Aug; 62(4):103710. PubMed ID: 37076359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sporadic Epstein syndrome with macrothrombocytopenia, sensorineural hearing loss and renal failure.
    Makino S; Kunishima S; Ikumi A; Awaguni H; Shinozuka J; Tanaka S; Maruyama R; Imashuku S
    Pediatr Int; 2015 Oct; 57(5):977-81. PubMed ID: 26387855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYH9 disorder: Identification and a novel mutation in patients with macrothrombocytopenia.
    Natesirinilkul R; Sosothikul D; Komwilaisak P; Pongtanakul B; Narkbunnum N; Yudhasompop N; Mekjarusgool P; Niparuck P; Boonyawat K; Kunishima S; Sirachainan N;
    Pediatr Blood Cancer; 2021 Jul; 68(7):e29055. PubMed ID: 33855781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.
    Pecci A; Klersy C; Gresele P; Lee KJ; De Rocco D; Bozzi V; Russo G; Heller PG; Loffredo G; Ballmaier M; Fabris F; Beggiato E; Kahr WH; Pujol-Moix N; Platokouki H; Van Geet C; Noris P; Yerram P; Hermans C; Gerber B; Economou M; De Groot M; Zieger B; De Candia E; Fraticelli V; Kersseboom R; Piccoli GB; Zimmermann S; Fierro T; Glembotsky AC; Vianello F; Zaninetti C; Nicchia E; Güthner C; Baronci C; Seri M; Knight PJ; Balduini CL; Savoia A
    Hum Mutat; 2014 Feb; 35(2):236-47. PubMed ID: 24186861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYH9 Associated nephropathy.
    Furlano M; Arlandis R; Venegas MDP; Novelli S; Crespi J; Bullich G; Ayasreh N; Remacha Á; Ruiz P; Lorente L; Ballarín J; Matamala A; Ars E; Torra R
    Nefrologia (Engl Ed); 2019; 39(2):133-140. PubMed ID: 30471777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital thrombocytopenia with nephritis - The first case of MYH9 related disorder in Serbia.
    Kuzmanović M; Kunishima S; Putnik J; Stajić N; Paripović A; Bogdanović R
    Vojnosanit Pregl; 2014 Apr; 71(4):395-8. PubMed ID: 24783421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A De Novo Mutation in MYH9 in a Child With Severe and Prolonged Macrothrombocytopenia.
    Li K; Jin R; Xu W; Shen Y; Lu K; Wu X
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e7-e10. PubMed ID: 32520844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic delay of MYH9-related disorder in Japan.
    Sakamoto A; Uchiyama T; Kaname T; Iguchi A; Ohara O; Ishimura M; Onum M; Kunishima S; Ishiguro A
    Br J Haematol; 2024 Jun; 204(6):2400-2404. PubMed ID: 38650331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease.
    Pecci A; Panza E; Pujol-Moix N; Klersy C; Di Bari F; Bozzi V; Gresele P; Lethagen S; Fabris F; Dufour C; Granata A; Doubek M; Pecoraro C; Koivisto PA; Heller PG; Iolascon A; Alvisi P; Schwabe D; De Candia E; Rocca B; Russo U; Ramenghi U; Noris P; Seri M; Balduini CL; Savoia A
    Hum Mutat; 2008 Mar; 29(3):409-17. PubMed ID: 18059020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and genetic features of seven children with MYH9-related disease].
    Hu Y; Ma JY; Liu HQ; Yang BX; Zhao SS; Zhang JL; Wu RH
    Zhonghua Er Ke Za Zhi; 2021 Nov; 59(11):968-972. PubMed ID: 34711033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.